Related Experiment Video
Updated: Oct 3, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Correlation between hypo-pituitarism and poor cognitive function using neuropsychological tests after aneurysmal
Raffaele Aspide1, Marianna Pegoli1, Marco Faustini Fustini2
1IRCCS Istituto delle Scienze Neurologiche di Bologna, Anesthesia and Neurointensive Care Unit, Bologna, Italy.
Hypopituitarism following aneurysmal subarachnoid hemorrhage (aSAH) is linked to cognitive impairment. Neuropsychological tests can help identify this neuroendocrine dysfunction in patients post-aSAH.
Area of Science:
- Neuroendocrinology
- Neurology
- Cognitive Science
Background:
- Hypopituitarism is a potential complication after aneurysmal subarachnoid hemorrhage (aSAH).
- The prevalence and impact of hypopituitarism on functional outcomes post-aSAH are not well-established.
- This study investigates the relationship between hypopituitarism and cognitive performance in aSAH patients.
Purpose of the Study:
- To correlate the presence of hypopituitarism with cognitive function in patients following aSAH.
- To assess the utility of neuropsychological tests in identifying neuroendocrine dysfunction post-aSAH.
Main Methods:
- A prospective cohort study involving 25 aSAH patients.
- Basal pituitary hormone testing was performed.
- Cognitive assessments using Montreal Cognitive Assessment (MoCA) and Mini Mental Status Examination (MMSE) were conducted at three time points: subacute (2 weeks), chronic (3-6 months), and follow-up (6-12 months).
Main Results:
- In the subacute phase, cognitive scores (MMSE, MoCA) were associated with low free triiodothyronine (fT3), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone.
- In the chronic phase, cognitive scores correlated with low free thyroxine (fT4), LH, and FSH.
- In the follow-up phase, cognitive performance remained associated with low fT4, LH, and FSH.
Conclusions:
- Neuropsychological tests, such as MoCA and MMSE, are valuable and cost-effective tools for detecting cognitive impairment in aSAH patients.
- Cognitive deficits identified by these tests can indicate underlying neuroendocrine dysfunction in the post-acute phase.
- Early identification of hypopituitarism through cognitive assessment may aid in patient management.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016